|
Montenegro MF, Sánchez-del-Campo L, Fernández-Pérez MP, Sáez-Ayala M, Cabezas-Herrera J, Rodríguez-López JN. Targeting the epigenetic machinery of cancer cells. Oncogene. 2015 Jan 8;34(2):135-43. doi: 10.1038/onc.2013.605. Review. PubMed PMID: 24469033.
AÑO: 2015; IF: 7.932
|
24469033
|
Montenegro MF, Collado-González Mdel M, Fernández-Pérez MP, Hammouda MB, Tolordava L, Gamkrelidze M, Rodríguez-López JN. Promoting E2F1-mediated apoptosis in oestrogen receptor-?-negative breast cancer cells. BMC Cancer. 2014 Jul 26;14:539. doi: 10.1186/1471-2407-14-539. PubMed PMID: 25064027; PubMed Central PMCID: PMC4122786.
AÑO: 2014; IF: 3.362
|
|
Sánchez-del-Campo L, Rodríguez-López JN. Targeting the methionine cycle for melanoma therapy with 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin. Int J Cancer. 2008 Nov 15;123(10):2446-55. doi: 10.1002/ijc.23813. PubMed PMID: 18729182.
AÑO: 2008; IF: 4.734
|
|
Castillo-González AC, Nieto-Cerón S, Pelegrín-Hernández JP, Montenegro MF, Noguera JA, López-Moreno MF, Rodríguez-López JN, Vidal CJ, Hellín-Meseguer D, Cabezas-Herrera J. Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma. BMC Cancer. 2015 May 10;15:385. doi: 10.1186/s12885-015-1402-y. PubMed PMID: 25956553; PubMed Central PMCID: PMC4435806.
AÑO: 2015; IF: 3.15
|
|
Montenegro MF, González-Guerrero R, Sánchez-del-Campo L, Piñero-Madrona A, Cabezas-Herrera J, Rodríguez-López JN. Targeting the epigenetics of the DNA damage response in breast cancer. Cell Death Dis. 2016 Apr 7;7:e2180. doi: 10.1038/cddis.2016.85. PubMed PMID: 27054335; PubMed Central PMCID: PMC4855664.
AÑO: 2016; IF: 5.965
|